Betnesol – N Eye, Ear And Nose 100 mg/350 mg/100 ml Solution

    Betnesol – N Eye, Ear And Nose 100 mg/350 mg/100 ml Solution

    S4


    1. What BETNESOL - N EYE, EAR AND NOSE DROPS is and what it is used for

    BETNESOL - N EYE, EAR AND NOSE DROPS contains betamethasone sodium phosphate, which is part of a group of medicines called corticosteroids. BETNESOL - N EYE, EAR AND NOSE DROPS also contains neomycin which prevents the development of bacterial infections.

    BETNESOL - N EYE, EAR AND NOSE DROPS is used for treating non infected inflammatory and /or allergic conditions characterised by swelling, itching, redness, pain of the eye, ear and nose. It is also used where bacterial infection of the ear or nose is present or suspected.

    2. What you need to know before you use BETNESOL - N EYE, EAR AND NOSE DROPS

    Do not use BETNESOL - N EYE, EAR AND NOSE DROPS:

    • If you are hypersensitive (allergic) to betamethasone sodium phosphate, neomycin or any of the other ingredients of BETNESOL - N EYE, EAR AND NOSE DROPS (listed in section 6).
    • If you have any kind of fungal, viral, tuberculosis (TB) or discharge producing infection.
    • In your eyes if you have a fever blister or cold sore on your eye area.
    • In your eyes if your doctor has diagnosed you with glaucoma (an eye disease that causes pain, redness and vision loss due to nerve that provides information to the brain being damaged and/or pressure inside the eye being increased).
    • If you have been diagnosed with a hole or tear in your ear drum.
    • In your eyes if you wear soft contact lenses.
    • In new-born children.
    • If you are pregnant or breastfeeding your baby (see Pregnancy, breastfeeding and fertility).

    Warnings and precautions

    Special care should be taken with BETNESOL - N EYE, EAR AND NOSE DROPS:

    • When used in the eye condition commonly referred to as “red eyes”, if the reason for the red eyes has not been confirmed, inappropriate use of BETNESOL - N EYE, EAR AND NOSE DROPS could lead to blindness.
    • When treatment over prolonged periods is applicable. This should only be done under the strict supervision of your health care provider to avoid complications like the following:
      • raised pressure inside the eye that leads to pain, redness and vision loss.
      • cataracts (a condition that causes clouding of the lenses and leads to vision problems and vision loss).
      • infections that are not immediately noticeable.
      • sensitivity of the skin to BETNESOL - N EYE, EAR AND NOSE DROPS.
      • bacteria becoming resistant to the neomycin in BETNESOL - N EYE, EAR AND NOSE DROPS.
    • If used for longer than 7 days and no improvement is noted as it can cause unexplained worsening of infections due to the infection masking effect of the betamethasone sodium phosphate in the BETNESOL - N EYE, EAR AND NOSE DROPS.
    • As the neomycin in BETNESOL - N EYE, EAR AND NOSE DROPS could cause an allergic response when used for a later course of treatment with BETNESOL - N EYE, EAR AND NOSE DROPS or any other neomycin containing product.
    • If no improvement is observed within 48 hours (2 (two) days). Speak to your health care provider if this is the case as they may need to refer you to an ophthalmologist (specialist eye doctor) to assure that a sore or fungal infection of the clear layer in the front of the eye or glaucoma (the condition where pain, redness and reduced vision is experienced due to the pressure inside the eye being increased) is not triggered.
    • If you experience blurred vision or other visual disturbances. This should also be reported to your health care provider for possible referral you to an ophthalmologist to find out the reason for the changes in vision. Which could be due to cataracts or glaucoma (mentioned above) or a rare disease like central serous chorioretinopathy (CSCR) where fluid builds up under the thin layer of tissue that lines the back of the eye.
    • If you have been diagnosed with any eye disease that causes thinning of the cornea (the transparent front part of the eye) or sclera (the white part of the eye) as use of BETNESOL - N EYE, EAR AND NOSE DROPS may lead to a further tear or hole in this area.
    • When being applied topically to open wounds or damaged skin as the neomycin in BETNESOL - N EYE, EAR AND NOSE DROPS may cause irreversible, partial or total deafness. This effect is especially relevant in the following cases:
      • Use of high doses.
      • Kidney and Liver disease.
      • Use in infants and small children.
    • If you’ve been diagnosed with having mitochondrial mutations or if your mother is deaf or has been diagnosed with having a mitochondrial mutation. The neomycin in BETNESOL - N EYE, EAR AND NOSE DROPS, if used in these instances, could lead to a condition where hearing or balance problems develop (ototoxicity).
    • When being used in the nose soon after nose surgery or if you’ve had an untreated nasal infection or have been diagnosed with pulmonary tuberculosis (TB).

    Children and adolescents

    • Prolonged treatment in infants should be avoided as it may cause suppression of the adrenal glands which can lead to loss of bodily functions that control food and salt usage which can lead to low blood pressure, weakness, nausea, vomiting and fever.
    • BETNESOL - N EYE, EAR AND NOSE DROPS should not be used in new-born children as their immature skin and kidneys may cause increased occurrence of side effects.
    • BETNESOL - N EYE, EAR AND NOSE DROPS may cause growth retardation in children, even if used at the usual doses.
    • When BETNESOL - N EYE, EAR AND NOSE DROPS has been prescribed for prolonged periods for nasal use, the child’s height will be carefully monitored by their doctor or health care practitioner and dose adjustments made to the lowest dose at which symptoms can be controlled. They may also be referred to a paediatric specialist.

    Other medicines and BETNESOL - N EYE, EAR AND NOSE DROPS

    Always tell your health care provider if you are taking any other medicine (this includes complementary or traditional medicines). Tell your doctor if you are taking any of the following:

    • Medicines such as the antiviral agents cobicistat as they inhibit an important enzyme (CYP3A) which assists in removing toxins or medicines from the body: Use of BETNESOL - N EYE, EAR AND NOSE DROPS with these medicines increases the risk of side effects and may require monitoring by your doctor or health care provider.

    Pregnancy, breastfeeding and fertility

    If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other health care provider for advice before taking this medicine. Corticosteroids such as the betamethasone sodium phosphate included in BETNESOL - N EYE, EAR AND NOSE DROPS has been shown to be cause malformation of the growing foetus in animals following application to the skin and for this reason malformations in humans is also possible. The neomycin in BETNESOL - N EYE, EAR AND NOSE DROPS may cause hearing or balance problems develop (ototoxicity) in the foetus. You should thus not take BETNESOL - N EYE, EAR AND NOSE DROPS if you are pregnant or breastfeeding your baby.

    Fertility: No data is available.

    3. How to use BETNESOL - N EYE, EAR AND NOSE DROPS

    Do not share medicines prescribed for you with any other person. Always use BETNESOL - N EYE, EAR AND NOSE DROPS exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

    The usual dose of BETNESOL - N EYE, EAR AND NOSE DROPS is:

    EYE:

    One or two (1 or 2) drops into the eye every one or two (1 or 2) hours until control is achieved, then the frequency may be reduced by your doctor or health care provider.

    EAR:

    Two to three (2 to 3) drops into the ear every two or three (2 or 3) hours until control is achieved, then the frequency may be reduced by your doctor or health care provider.

    NOSE:

    Two or three (2 or 3) drops into each nostril two or three (2 or 3) times daily.

    Your doctor or health care provider will prescribe the lowest effective dose for the shortest possible time period. Tell your doctor or health care provider if the eye has not responded within 48 hours, he or she may then refer you to an ophthalmologist. The same dosage as for adults may be prescribed for use in children, but may be reduced in infants. Use in new-born children however is not recommended. Due to the growth retardation that is possible in children, the lowest dose that controls symptoms will be prescribed. Due to the side effects that can occur due to suppression of the adrenal glands in infants, only short term treatment, with the lowest dose, of the least potent medicine that will control the disease will be prescribed. Your doctor will tell you how long your treatment with BETNESOL - N EYE, EAR AND NOSE DROPS will last. Do not stop treatment early. If you have the impression that the effect of BETNESOL - N EYE, EAR AND NOSE DROPS is too strong or too weak, tell your doctor or pharmacist.

    If you use more BETNESOL - N EYE, EAR AND NOSE DROPS than you should

    In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre. The quantity of betamethasone sodium phosphate present in BETNESOL - N EYE, EAR AND NOSE DROPS is such that absorption into the body is unlikely to occur to any significant extent, for this reason overdosage is unlikely. However, appropriate care should be taken as noted under section 2. (What you need to know before you use BETNESOL - N EYE, EAR AND NOSE DROPS) and 4. (Possible side effects)

    If you forget to use BETNESOL - N EYE, EAR AND NOSE DROPS

    Do not take a double dose to make up for forgotten individual doses.

    4. Possible side effects

    BETNESOL - N EYE, EAR AND NOSE DROPS can have side effects. Not all side effects reported for BETNESOL - N EYE, EAR AND NOSE DROPS are included in this leaflet. Should your general health worsen or if you experience any untoward effects while using BETNESOL - N EYE, EAR AND NOSE DROPS, please consult your health care provider for advice.

    If any of the following happens, stop using BETNESOL - N EYE, EAR AND NOSE DROPS and tell your doctor immediately or go to the casualty department at your nearest hospital:

    • Rash or itching that is accompanied by swelling of the hands, feet, face, lips and mouth or throat, which causes difficulty in swallowing or breathing. These are all very serious side effects. If you have them you may have had a serious reaction to one of the ingredients in BETNESOL - N EYE, EAR AND NOSE DROPS and you will require urgent medical attention or hospitalisation.

    Tell your doctor as soon as possible if you notice any of the following:

    • Blurred vision, vision loss or cloudy patches on the clear layer of the front of the eye.
    • Painful and redness of eye.
    • Increased sensitivity to light.
    • Excessive tears or discharge.
    • Ulcers or a tear of the front part of the eye.
    • Infection, inflammation of the front part of the eye.
    • Dilated pupils.
    • Drooping of the upper eyelid.
    • Partial or total loss of hearing.
    • Ulceration or a tear of the thin wall dividing your nose into the 2 nasal passages.
    • Wheezing, dry cough and shortness of breath (bronchial asthma).

    These are all serious side effects that may need referral to a specialist.

    Tell your doctor if you notice any of the following:

    Frequent side effects:

    • Dryness, irritation of the nose.

    Less frequent side effects:

    • Hearing or balance problems (ototoxicity).

    Side effects with an unknown frequency:

    • Infection that are not immediately noticeable.
    • Unexplained worsening of infections due to the masking of the infection symptoms by the betamethasone sodium phosphate in BETNESOL - N EYE, EAR AND NOSE DROPS.
    • Symptoms like weight gain, particularly in the face and the upper back and neck region, facial male-pattern hair growth, increased bruising, stretch marks and acne (collectively these are referred to as cushingoid symptoms).
    • Symptoms like tiredness, loss of appetite, stomach pain, joint pain, nausea, vomiting, diarrhoea, irritability and depression, decreased sexual development of the body (collectively, these are all signs of adrenal disease).
    • Growth retardation in children and adolescents.
    • Mental disturbances such as acting different than usual, hyperactivity, sleep problems, anxiety, depression and aggressive, rude and abusive behaviour (these effects are more common in children).
    • Irritation of the eyes.
    • Irritation or swelling inside the nose.
    • Nausea.
    • Skin reactions like redness and itchiness.
    • The development of itchy, round, red welts on the skin. The welts vary in size and appear and fade repeatedly (urticaria).
    • Headache.
    • Light-headedness.
    • Nose bleeds.
    • Worsening of blocked nose.
    • Smell and taste disturbances.
    • Irritation, burning, stinging, itching at the site of administration.

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. Reporting can also be done directly to Adcock Ingram Limited at: E-mail: [email protected] Tel: 011 635 0134. By reporting side effects, you can help provide more information on the safety of BETNESOL - N EYE, EAR AND NOSE DROPS.

    5. How to store BETNESOL - N EYE, EAR AND NOSE DROPS

    Store all medicines out of reach of children. Store at or below 25 °C. Protect from light. Avoid freezing. Eye drops should be discarded within 28 days of first opening the container. Do not store in a bathroom. Do not use after the expiry date stated on the label /carton. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets).

    Important Disclaimer

    The Betnesol – N Eye, Ear And Nose 100 mg/350 mg/100 ml Solution professional information leaflet below is the property of Adcock Ingram Limited and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Betnesol – N Eye, Ear And Nose 100 mg/350 mg/100 ml Solution
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites